| Transfer of knowledge and technology developed at the ICIQ to the pharmaceutical and chemical industry is a fundamental aspect of the institute's mission. Several strategies to maximize knowledge and technology transfer have been developed and set-up. |
In first place, industrial relevant inventions arising from the institute's research are identified and protected as industrial property; subsequently they are valorized to a stage where they can be licensed to an industry or a spin-off company (please check our
technology portfolio).
Moreover, the institute actively pursuits the establishment of contract research projects between companies and ICIQ's research groups, which take advantage of the group's research expertise.
Large collaborative research projects between an industry and the ICIQ (joint units) have been set up with two companies:
Laboratorios Dr. Esteve and
Henkel. These projects involve a dedicated laboratory and take advantage of ICIQ group leaders' assessment and of ICIQ's state of the art instrumentation facilities.
Finally, two technology development units have been created:
Crysforma and
CSOL. These units combine a profound scientific knowledge with state of the art scientific instrumentation to give response to a specific industrial need.
Crysforma is dedicated to give scientific and technological support in the field of pharmaceutical solid state development; and
CSOL is oriented to commercially exploit the diverse catalyst libraries and catalyst know-how developed at the institute.
| Industry/ICIQ joint units |
ICIQ's technology development units |